Spine Empirical Spine Announces First Commercial LimiFlex(R) Cases at Stanford Medicine, Marking U.S. Launch of Motion-Preserving Alternative to Fusion for Degenerative Spondylolisthesis byJosh SandbergMay 19, 2026
Regulatory Spine Top Stories FDA Grants PMA Approval to LimiFlex™ Dynamic Sagittal Tether byTim AllenFebruary 18, 2026
Regulatory Spine Empirical Spine Completes Full Premarket Approval (PMA) Submission to FDA for LimiFlex™ Dynamic Sagittal Tether™ byJosh SandbergDecember 19, 2022
Regulatory Spine FDA Accepts & Closes Empirical Spine’s LimiFlex™ PMA Module II As A Motion-Preserving Alternative To Lumbar Fusion byJosh SandbergJuly 13, 2022
Spine Empirical Spine Advances LimiFlex™ As A New Motion-Preserving, Minimally Invasive Standard In Spine Surgery byJosh SandbergFebruary 1, 2022
Spine Top Stories Empirical Spine Presents Data from Study of the LimiFlex™ Tension Band at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum 2021 byJosh SandbergNovember 2, 2021
Financial Spine Top Stories Empirical Spine Closes $10 Million Series B Financing byJosh SandbergJune 2, 2021
Regulatory Spine Empirical Spine Receives FDA Breakthrough Device Designation for the LimiFlex Device Targeting Degenerative Spondylolisthesis byJosh SandbergApril 1, 2021
Spine Empirical Spine Initiates PMA Submission Process for FDA Approval of LimiFlex for Degenerative Spondylolisthesis byJosh SandbergFebruary 25, 2021
Spine Empirical Spine Completes Enrollment in Pivotal IDE Clinical Trial Studying LimiFlex in Degenerative Spondylolisthesis byChris StewartJuly 17, 2020
